Quintiles bets on a big 2016 as revenue rolls in

Quintiles CEO Tom Pike

Quintiles ($Q), the world's largest CRO, is expecting its revenue to jump as much as 8.5% in 2016 on the heels of a record year.

The North Carolina-headquartered company banked $1.3 billion in service revenue in the fourth quarter, good for 6.1% growth, and posted $4.3 billion for the full year, which is 3.9% above 2014. At constant currency rates, Quintiles 2015 revenue grew 9% over the prior year, the company said.

The CRO's banner product development business led the way with $3.2 billion in annual revenue, up 3%, while its integrated healthcare serves segment grew 6.3% to $1.1 billion on the year.

Net income grew about 9% to $388.3 million in 2015, Quintiles said.

Now Quintiles is projecting 2016 revenue growth of between 7% and 8.5%, assuming global currencies stay static, which would amount to as much as $4.7 billion.

To get there, the company is counting on its $12 billion backlog, bolstered by roughly $1.5 billion in net new business stemming from the fourth quarter.

- read the statement (PDF)

Suggested Articles

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.

Aetion has raised $50 million so far, and it plans to enhance its platform to support more complex therapeutic areas and expand its team.

Charles River partners with PathoQuest to offer clients NGS solutions for biologics viral contamination testing and cell-line genetic characterization.